Greenrose Holding Company Stock Collapses 99.99% on Pink Sheets

The Greenrose Holding Company Inc. (GNRSU) has experienced a catastrophic collapse, with GNRSU stock plummeting 99.99% to trade at just $0.000001 per share on the OTC Pink Sheets market. The cannabis producer, which went public in February 2020, now trades at penny stock levels with a market cap of just $13. This dramatic decline reflects severe operational and financial distress for the Amityville, New York-based company. Investors holding GNRSU stock face potential total loss as the company battles liquidity and compliance challenges.

GNRSU Stock Price Collapse and Market Metrics

GNRSU stock trades at $0.000001, down from $0.15 just days ago. The stock trades below its 50-day average of $0.15 and 200-day average of $0.15, signaling sustained downward pressure. Trading volume remains extremely thin at just 145 shares, with minimal liquidity for buyers or sellers. The company’s market cap has evaporated to $13, making it one of the smallest publicly traded entities.

The earnings per share stands at $3.097, yet the price-to-earnings ratio is essentially zero at 0.0000000008, reflecting the stock’s nominal valuation. This disconnect between earnings and price suggests severe market distrust. The year-to-date decline of 99.99977% represents one of the most severe stock collapses on record. Investors who purchased GNRSU stock near its $0.151 year high have lost virtually their entire investment.

Cannabis Industry Challenges and Greenrose’s Position

Greenrose operates in the healthcare sector as a specialty cannabis manufacturer, cultivating and processing medical cannabis products through subsidiaries. The company employs 910 full-time workers across its New York operations. However, the cannabis industry faces significant regulatory headwinds, including federal prohibition and state-level licensing restrictions that limit market access and financing options.

The company’s revenue per share reached $1.58 trailing twelve months, yet profitability metrics show deterioration. Net income per share of $1.12 contrasts sharply with the stock’s near-zero valuation, indicating market skepticism about earnings quality. Operating cash flow per share of $0.51 provides some operational support, but free cash flow of just $0.16 per share reveals limited financial flexibility. Track GNRSU on Meyka for real-time updates on this distressed cannabis stock.

Financial Distress and Liquidity Crisis

Greenrose faces severe balance sheet deterioration with a current ratio of just 0.21, indicating the company cannot cover short-term obligations with current assets. Working capital stands at negative $103.4 million, while tangible asset value is negative $116.3 million. These metrics signal insolvency risk and potential bankruptcy proceedings. The debt-to-equity ratio of 1.57 shows the company carries substantial leverage relative to shareholder equity.

Cash per share of $0.56 provides minimal runway for operations. The company’s interest coverage ratio of 4.48 suggests it can service debt payments, but deteriorating cash generation raises questions about sustainability. Days of inventory outstanding at 439 days reveals slow-moving cannabis inventory, tying up precious capital. Management must act quickly to stabilize operations or face potential delisting from OTC markets.

Meyka AI Rates GNRSU with Grade B Hold

Meyka AI rates GNRSU with a grade of B, suggesting a Hold rating despite the stock’s catastrophic price decline. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score of 63.41 reflects mixed fundamentals: strong profitability margins offset by severe balance sheet weakness and liquidity constraints. These grades are not guaranteed and we are not financial advisors.

The B grade indicates the company retains some operational viability, with gross profit margins of 59% and operating margins of 39% showing the core business generates cash. However, negative working capital and tangible asset values create existential risk. Investors should recognize this grade reflects historical data and does not predict future performance. The extreme stock price collapse suggests market participants have lost confidence in management’s ability to execute a turnaround.

Final Thoughts

GNRSU stock’s 99.99% collapse represents a complete loss of investor confidence in Greenrose Holding Company. The company faces existential challenges including severe liquidity constraints, negative working capital of $103.4 million, and minimal trading volume that prevents orderly exit for shareholders. While the company maintains positive operating margins and generates revenue, the balance sheet deterioration and near-zero market valuation suggest potential bankruptcy or delisting. Investors holding GNRSU stock should consult financial advisors immediately, as recovery appears unlikely without dramatic operational restructuring or capital infusion.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.